CVE-2025-3423: IBM Aspera Faspex 5 cross-site scripting
Vulnerability summary
CVE-2025-3423 is a medium (CVSS 5.4) vulnerability in ibm aspera_faspex. EPSS estimates a 0.29% chance of exploitation in the next 30 days, higher than 21.4% of scored vulnerabilities.
Not severe (CVSS 5.4, network access); no exploitation reported by the 5 checked sources
Source freshness unavailable
How is this decided?Timeline
- 13-04-2025PublishedVulnerability first disclosed.
- 01-09-2025Last modifiedVulnerability information updated.
Description
IBM Aspera Faspex 5.0.0 through 5.0.11 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
CVSS metrics
2 scores · 2 sources · 1 version- NVDNIST5.4MediumCVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
EPSS trend
Probability
0.29%
Chance of exploitation in the next 30 days
Percentile
21%
Versus all other CVEs
30-day change
Increase +0.01 pp
From 0.28% on 11-10-2026
Known exploited
Compare KEV catalogsNot in the CISA KEV catalog.
Not in the ENISA CNW catalog.
Not in the CIRCL catalog.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root causeAffected systems
Known conditions: network-reachable, low-privilege account, user interaction (CVSS vector). Other conditions: not stated in public data.
Ibm1 product
- aspera_faspex≥ 5.0.0, ≤ 5.0.11 | ≥ 5.0.0, < 5.0.12
1 vendor · 1 product